Jazz Pharmaceuticals
JAZZ
#1695
Rank
A$17.64 B
Marketcap
A$281.23
Share price
-0.15%
Change (1 day)
51.00%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -A$0.97 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are A$4.26 Billion. a decrease over its 2024 earnings that were of A$0.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.88 Billion-233.49%
2024 A$0.65 B57.87%
2023 A$0.41 B-179.92%
2022 -A$0.52 Billion230.37%
2021 -A$0.16 Billion-141.02%
2020 A$0.38 B-39.45%
2019 A$0.63 B-14.2%
2018 A$0.73 B20.03%
2017 A$0.61 B-17.15%
2016 A$0.73 B22.14%
2015 A$0.60 B187.64%
2014 A$0.21 B-50.79%
2013 A$0.42 B73.63%
2012 A$0.24 B41.69%
2011 A$0.17 B116.61%
2010 A$80.17 M262.77%
2009 A$22.09 M-111.33%
2008 -A$0.2 Billion1.31%
2007 -A$0.2 Billion77.8%
2006 -A$0.11 Billion36.59%
2005 -A$79.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.68 B-2,704.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
A$2.90 B-433.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-A$3.32 Billion 280.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$2.98 B-442.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel